Risk group | Phenotype of families | No. of families | No. of families with mutations (%) in | ||||||
---|---|---|---|---|---|---|---|---|---|
BRCA1 | BRCA2 | BRCA1/2 | |||||||
Small-range | LGRs | All | Small-range | LGRs | All | ||||
 | All families | 539 | 101 (18.7) | 9 (1.7) | 110 (20.4) | 23 (4.3) | 0 (0) | 23 (4.3) | 133 (24.7)a |
Female breast cancer families | 447 | 67 (15.0) | 7 (1.6) | 74 (16.6) | 18 (4.0) | 0 (0) | 18 (4.0) | 92 (20.6) | |
A1 | 1 case ≤ 30 years | 203 | 20 (9.8) | 2 (1.0) | 22 (10.8) | 3 (1.5) | 0 (0) | 3 (1.5) | 25 (12.3) |
A2 | 2 cases, >1 diagnosed ≤50 years | 131 | 20 (15.3) | 4 (3.0) | 24 (18.3) | 6 (4.6) | 0 (0) | 6 (4.6) | 30 (22.9) |
A3 | >3 cases, >1 diagnosed ≤50 years | 113 | 27 (23.9) | 1 (0.9) | 28 (24.8) | 9 (8.0) | 0 (0) | 9 (8.0) | 37 (32.7) |
A4 | Male breast cancer families | Â | Â | Â | Â | Â | Â | Â | Â |
>1 case of male breast cancer | 27 | 1 (3.7) | 0 (0) | 1 (3.7) | 4 (14.8) | 0 (0) | 4 (14.8) | 5 (18.5) | |
B | Breast-ovarian cancer families | Â | Â | Â | Â | Â | Â | Â | Â |
>1 breast cancer and >1 ovarian cancer | 65 | 33 (50.8) | 2 (3.0) | 35 (53.8) | 1 (1.5) | 0 (0) | 1 (1.5) | 36 (55.4) |